HGH Liquid (PEN) 90 IU mg/ml 30 ml |

About HGH Liquid (PEN) | HilmaBiocare

Somatropin (HGH) - Hilma Biocare

Somatropin is a recombinant human growth hormone (rhGH) that is structurally identical to endogenous growth hormone produced by the pituitary gland. It is a 191–amino acid protein and has established prescription use for specific medical conditions (such as certain growth hormone deficiencies) under specialist supervision. Growth hormone affects metabolism and tissue processes, partly through stimulation of IGF-1 production.

General Overview

Class: Recombinant human growth hormone (rhGH)
Structure: Somatropin (191–amino acid polypeptide)
Context of use: Prescription medical use under professional supervision for approved indications

Potentially Observed Effects
(based on pharmacological action and clinical use)

Effects on body composition via metabolic and anabolic signaling pathways
Support of tissue repair processes and collagen synthesis
Changes in energy balance and fluid distribution (individual response varies)
Increased IGF-1 levels as part of its physiological mechanism

Safety Information

Somatropin may be associated with side effects and clinically relevant risks. Reported adverse effects can include fluid retention (edema), joint or muscle pain, numbness or tingling (including carpal tunnel–type symptoms), and changes in glucose metabolism (including reduced insulin sensitivity). In clinical settings, IGF-1 levels are typically monitored. Individual responses vary, and use should be guided by qualified medical professionals with appropriate assessment and follow-up.

Disclaimer: This text is provided for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always comply with the laws of your country and use prescription medicines only under qualified medical supervision.